SolAeroMed Inc.
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability and Efficacy Of S-1226 in Moderate Severity Covid-19 Bronchiolitis/Pneumonia (NCT04738136) | SolAeroMed Inc. | 2021-09-15 |
| Safety, Tolerability and Efficacy of S-1226 in Post-COVID-19 Subjects With Persistent Respiratory Symptoms. (NCT04949386) | SolAeroMed Inc. | 2021-09-01 |
| Safety, Tolerability and Efficacy of S-1226 in Cystic Fibrosis and Non CF Bronchiectasis (NCT03903913) | SolAeroMed Inc. | 2019-08-08 |
Track SolAeroMed Inc. automatically
Every clearance here is in the API, with alerts when new ones post.